| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |